Search

everythinglearnresearchcommunity

for

Search:↓

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

Caesalpinia bonduc seed extracts may help treat enlarged prostate in rats.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

Centella asiatica extract may help promote hair growth.

Identifying nonclassic congenital adrenal hyperplasia and carriers of CYP21 mutations is challenging, and genetic counseling is recommended due to their prevalence.

An 84-year-old woman's hair loss was due to a rare condition called Leydig cell hyperplasia, which was treated with surgery.

Women with nonclassical congenital adrenal hyperplasia may have a higher risk of fertility issues and miscarriages, and should get genetic counseling.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

A woman's male-like physical changes were caused by two rare ovarian conditions.

Children with classic congenital adrenal hyperplasia have thicker heart fat and more heart and blood vessel risk factors, especially if their condition is not well-controlled.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

LED light helps human hair root cells grow and move by activating certain cell pathways.

Urinary PSA could be an early marker for enlarged prostate.

Nonclassic congenital adrenal hyperplasia is a common genetic disorder that can cause a range of symptoms and requires personalized treatment.

Hair loss linked to prostate enlargement; stress and family history important factors.

Gene variation affects prostate issues and hair loss.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Castration is preferred for non-breeding male dogs with BPH, but other treatments are available with specific pros and cons.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

Certain natural compounds called terpenes may help prevent prostate cancer.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Finasteride and dutasteride reduce neurosteroid production, possibly helping treat glioblastoma.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Urtica dioica extract may help treat androgenic skin diseases by reducing a specific gene's activity.